The demand for natural extract drugs will increase during the forecast period. This trend will bring a positive change in the market. The increasing number of individuals with iodine deficiency results in growing cases of thyroid gland disorders such as hypothyroidism will drive the market. The deficiency is likely to rise during the forecast period in regions like Asia. The high demand for levothyroxine drug will increase the focus of vendors toward the development of thyroid disorder drugs, which drive the market during the forecast period.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

Highlights

Key pipeline

PART 05: Market landscape

Market overview

Five forces analysis

PART 06: Market segmentation by type

Hypothyroidism

Hyperthyroidism

PART 07: Geographical segmentation

Thyroid gland disorder treatment in Americas

Thyroid gland disorder treatment market in EMEA

Thyroid gland disorder treatment market in APAC

PART 08: Market drivers

Rising global awareness programs

Increasing demand for levothyroxine

Growing patient population with iodine deficiency

PART 09: Impact of drivers

PART 10: Market Challenges

High entry barrier

Product recall

Side effects leading to lesser patient adherence

PART 11: Impact of drivers and challenges

PART 12: Market trends

Rising focus on emerging economies

Increased outsourcing of non-core activities

Growing focus on natural drugs

PART 13: Vendor landscape

Competitive scenario

PART 14: Key vendor analysis

Abbott

AbbVie

Allergan

Merck Sharp & Dohme

Pfizer

RLC LABS

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio